CONCLUSIONS:
Whereas we hypothesized excessive benzodiazepine and hypnotic usage pre-and post-index AD, we noted lower than expected usage. We did not expect the pattern of increased atypical antipsychotic usage on the same day or subsequent to an index AD. We speculate that continuing medical education of physicians may be contributing to a decrease in the putative misuse of benzodiazepines and hypnotics. The prior use profile of treated patients exhibited a significant time trend toward higher prior use and completed therapy rates decreased for all products. Patients treated initially with fluoxetine and sertraline were significantly more likely to complete therapy than TCA patients (odds ratios: 4.73 before change, 2.10 after for fluoxetine; 2.15 and 1.24 for sertaline, respectively).
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THE IMPACT OF ADDING SSRI
Completion rates for paroxetine were not statistically different from TCAs (odds ratios: 1.27, P ϭ 0.3147 before and 1.017, P ϭ 0.3943 after). Completed therapy was associated with reductions in ambulatory care costs in both periods. However, increased drug costs completely offset these savings after the formulary change.
CONCLUSION:
The change in Medi-Cal formulary policy adding fluoxetine and paroxetine may have provided new treatment options for more severely ill, refractory patients that may have resulted in a modest increase in costs.
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THE BURDEN OF OSTEOPOROSIS TO THE STATE OF FLORIDA: PROJECTIONS FOR 2000-2010
Burge RT, Worley D Procter & Gamble Pharmaceuticals, Cincinnati, OH, USA Osteoporosis affects over 28 million Americans, causing over $13.8 billion in healthcare costs annually. Aging of the population is expected to increase the national burden of osteoporosis, though little is known about state level impacts. In Florida, there is a large and growing atrisk population (6.2 million age 45ϩ and 2.7 million age 65ϩ). In 1998, there were 25,000, 4500, 1600 and 12,500 hip, vertebral, forearm/wrist and other fracture hospitalizations, respectively. OBJECTIVE: To predict the costs of osteoporosis in Florida over the next decade. METHODS: Inpatient costs were estimated from Florida hospital discharge data and primary and long-term care costs were obtained from published national estimates. Costs of osteoporosis for women age 50-100 were pre-
